e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Respiratory physiotherapy: interventions and technologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use and cost of intermittent oxygen therapy in COPD
B. O‘Neill, J. M. Bradley, L. Heaney, M. Riley, C. O’Neill, J. MacMahon (Newtownabbey, Belfast, United Kingdom)
Source:
Annual Congress 2004 - Respiratory physiotherapy: interventions and technologies
Session:
Respiratory physiotherapy: interventions and technologies
Session type:
Poster Discussion
Number:
4258
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. O‘Neill, J. M. Bradley, L. Heaney, M. Riley, C. O’Neill, J. MacMahon (Newtownabbey, Belfast, United Kingdom). Use and cost of intermittent oxygen therapy in COPD. Eur Respir J 2004; 24: Suppl. 48, 4258
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The use of ambulatory oxygen therapy in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 65s
Year: 2004
Our experience of 200 patients: Usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Benefits of long-term oxygen therapy among COPD patients with moderate resting desaturation
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
High-flow oxygen therapy in COPD patients: Optimised oxygen delivery
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Use of low flow oxygen therapy in a population
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
International approaches to the prescription of long-term oxygen therapy
Source: Eur Respir J 2001; 18: 909-913
Year: 2001
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD
Source: Annual Congress 2004 - Exercise and systemic effects in COPD
Year: 2004
Patients’ perception on long-term domiciliary oxygen therapy
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Does long-term oxygen therapy reduce hospitalisation in hypoxaemic COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 274s
Year: 2001
Indications for oxygen treatment in COPD
Source: Annual Congress 2008 - PG14 - COPD: management of advanced disease
Year: 2008
Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Management of the COPD patient with chronic respiratory insufficiency: long-term oxygen therapy, invasive and non-invasive ventilation and other approaches
Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD
Year: 2004
Benefits of high-flow nasal cannula oxygen therapy on exercise capacity following acute exacerbation in ILD patients
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
The impact of The Danish Oxygen Register on adherence to guidelines for long term oxygen therapy in COPD patients
Source: Annual Congress 2005 - Chronic care in respiratory failure
Year: 2005
An audit on the effect of a hospital oxygen therapy guideline on oxygen prescription
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
The use of oxygen prescription wristbands significantly improves patient safety on an acute respiratory ward
Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions
Year: 2015
Inhaled corticosteroids and survival in patients with COPD receiving long-term home oxygen therapy
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
The use of long term home oxygen therapy reduces hospitalizations and mortality in COPD patients
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Nocturnal hypercapnia and oxygen therapy in COPD patients
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
The influence of complex ICS/LABA therapy on oxygen consumption in COPD patients
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept